Hill-Rom Holdings Company Profile (NYSE:HRC)

Hill-Rom Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Hill-Rom Holdings declared a quarterly dividend on Wednesday, July 19th. Shareholders of record on Friday, September 15th will be given a dividend of $0.18 per share on Friday, September 29th. This represents a $0.72 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, September 14th. View Hill-Rom Holdings' Dividend History.

Hill-Rom Holdings Inc (NYSE:HRC) released its earnings results on Friday, July, 28th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. The company had revenue of $689.10 million for the quarter, compared to analysts' expectations of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. Hill-Rom Holdings's quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.81 earnings per share. View Hill-Rom Holdings' Earnings History.

Hill-Rom Holdings is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Hill-Rom Holdings.

Hill-Rom Holdings issued an update on its fourth quarter earnings guidance on Friday, July, 28th. The company provided EPS guidance of $1.26-1.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.33. The company issued revenue guidance of +3 to 4% to ~$727-734 million, compared to the consensus revenue estimate of $751.39 million.

5 analysts have issued 1 year price targets for Hill-Rom Holdings' shares. Their predictions range from $84.00 to $93.00. On average, they anticipate Hill-Rom Holdings' share price to reach $87.80 in the next year. View Analyst Ratings for Hill-Rom Holdings.

Here are some recent quotes from research analysts about Hill-Rom Holdings stock:

• 1. According to Zacks Investment Research, "Over the last three months, Hill-Rom has been underperforming the broader industry. Moreover, it exited the last reported quarter on a mixed note with earnings ahead of estimates but revenues missing the same. Also, decrease in Patient Support Systems revenues was disappointing. Moreover, a decline in reported gross margin was dampening. Also, lowered full year guidance suggests dull prospects ahead. On a positive note, Hill-Rom saw a solid year-over-year increase in revenues on strong international growth. Hill-Rom currently aims to gain traction in the untapped international market on successful execution. The company is focusing on product innovation through research and development. Also, its launches slated for the fourth quarter are pumping up investors’ confidence. With regard to this, the commercial launch of its Centrella Med-Surg platform is worth a mention." (9/18/2017)
• 2. Needham & Company LLC analysts commented, "We are initiating coverage of HRC with a Buy rating. Recent acquisitions have diversified HRC’s business and should drive stronger margin expansion and faster EPS growth. Additionally, new products should drive higher organic revenue growth. And while large (>$1B) acquisitions are probably off the table for now, we see potential for additional tuck-in deals over the next 12-18 months." (6/29/2017)

Some companies that are related to Hill-Rom Holdings include Steris Plc (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), DexCom (DXCM), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), NuVasive (NUVA), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Halyard Health (HYH), Inogen (INGN), MiMedx Group (MDXG), CONMED Corporation (CNMD), OraSure Technologies (OSUR) and Asante Solutions (PUMP).

Hill-Rom Holdings' management team includes the folowing people:

• Rolf A. Classon, Independent Chairman of the Board
• Carlos Alonso, President, Senior Vice President
• Dirk Ehlers, Senior Vice President, President - Surgical Solutions
• John J. Greisch, President, Chief Executive Officer, Director
• Steven J. Strobel, Chief Financial Officer, Senior Vice President
• Kenneth F. Meyers, Chief Human Resource Officer, Senior Vice President
• Deborah Rasin, Senior Vice President, Chief Legal Officer, Secretary
• Andreas G. Frank, Senior Vice President - Corporate Development and Strategy
• Alton Shader, Senior Vice President and President - Front Line Care
• Jason A. Richardson, Chief Accounting Officer, Vice President, Controller

Hill-Rom Holdings' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.73%), BlackRock Inc. (7.93%), FMR LLC (5.90%), State Street Corp (2.55%), Franklin Resources Inc. (2.41%) and Fisher Asset Management LLC (2.32%). Company insiders that own Hill-Rom Holdings stock include Alton Shader, Andreas G Frank, Carlyn D Solomon, John J Greisch and Paul Sherwood Johnson. View Institutional Ownership Trends for Hill-Rom Holdings.

Hill-Rom Holdings' stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, FMR LLC, Franklin Resources Inc., Prudential PLC, LSV Asset Management, Thrivent Financial For Lutherans, Cooke & Bieler LP and Westfield Capital Management Co. LP. Company insiders that have sold Hill-Rom Holdings stock in the last year include Alton Shader, Andreas G Frank, Carlyn D Solomon, John J Greisch and Paul Sherwood Johnson. View Insider Buying and Selling for Hill-Rom Holdings.

Hill-Rom Holdings' stock was bought by a variety of institutional investors in the last quarter, including Koch Industries Inc., Lord Abbett & CO. LLC, Bank of New York Mellon Corp, Hood River Capital Management LLC, Wells Fargo & Company MN, Janus Henderson Group PLC, BlackRock Inc. and Arrowstreet Capital Limited Partnership. View Insider Buying and Selling for Hill-Rom Holdings.

Shares of Hill-Rom Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Hill-Rom Holdings stock can currently be purchased for approximately $73.81.